BALTIMORE, Md. — A new study from Johns Hopkins Bloomberg School of Public Health is highlighting the similarities between biosimilar drugs and the biologic drugs they seek to imitate. The study looked at scientific literature around biosimilars to conclude that “biosimilar drugs have very similar safety and effectiveness as their counterparts.”
PITTSBURGH — Giant Eagle Pharmacy has received full Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based independent, nonprofit healthcare accrediting organization that assesses quality standards for the healthcare industry.
For the second year in a row, spending on medicines in 2015 grew by double-digits, increasing 12.2% on an invoice basis to $424.8 billion, according to the IMS Institute for Healthcare Informatics’ medicine report on spending for 2015.
SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Ipsen Biopharmaceuticals’ Dysport (abobotulinumtoxinA), the company announced Monday. The drug can now be used to treat lower limb spasticity in pediatric patients ages 2 years and older.
NEW YORK — In a move aimed at bolstering its position in the gene therapy field, Pfizer on Monday announced its acquisition of Bamboo Therapeutics. The Chapel Hill, N.C.-based company focuses on developing gene therapies for patients with rare diseases related to neuromuscular and central nervous system conditions.
HARRISBURG, Pa. — Pennsylvania Gov. Tom Wolf last week signed a bill that will increase patient access to interchangeable biologic medicines. Wolf’s signing of Senate Bill 514 has earned him praise from both the Biotechnology Innovation Organization (BIO) and Pennsylvania Bio.
ARLINGTON, Va. – The National Association of Chain Drug Stores on Wednesday publicly thanked the 37 members of the U.S. House of Representatives who have sent a letter to House and Senate negotiators, urging them to advance a TRICARE pilot program as part of the FY2017 National Defense Authorization Act.
CINCINNATI - Kroger on Wednesday announced an agreement for Axium Pharmacy Holdings to acquire the outstanding shares of Modern HC Holdings, a leading specialty pharmacy, to create a combined specialty pharmacy that will operate as a wholly-owned subsidiary of Kroger.
